rs269951

Variant names:

Your query was ambiguous. Multiple possible variants found:

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001127255.2(NLRP7):c.2682T>C(p.Tyr894Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.561 in 1,610,306 control chromosomes in the GnomAD database, including 255,126 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.55 ( 23580 hom., cov: 31)

Exomes 𝑓: 0.56 ( 231546 hom. )

Consequence

NLRP7
NM_001127255.2 synonymous

Scores

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.264

Variant links:

Genes affected

NLRP7 (HGNC:22947): (NLR family pyrin domain containing 7) This gene encodes a member of the NACHT, leucine rich repeat, and PYD containing (NLRP) protein family. It has an N-terminal pyrin domain, followed by a NACHT domain, a NACHT-associated domain (NAD), and a C-terminal leucine-rich repeat (LRR) region. NLRP proteins are implicated in the activation of proinflammatory caspases through multiprotein complexes called inflammasomes. This gene may act as a feedback regulator of caspase-1-dependent interleukin 1-beta secretion. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]

NLRP7 links:

NCR1 (HGNC:6731): (natural cytotoxicity triggering receptor 1) Predicted to be involved in cellular defense response; regulation of natural killer cell mediated cytotoxicity; and signal transduction. Predicted to act upstream of or within defense response to virus and detection of virus. Predicted to be located in cell surface. Predicted to be part of SWI/SNF complex. Predicted to be active in plasma membrane. Biomarker of acquired immunodeficiency syndrome; anogenital venereal wart; hepatitis C; and lymphoproliferative syndrome. [provided by Alliance of Genome Resources, Apr 2022]

NCR1 links:

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4

Computational evidence support a benign effect (BayesDel_noAF=-1.03).

BP6

Variant 19-54930627-A-G is Benign according to our data. Variant chr19-54930627-A-G is described in ClinVar as [Benign]. Clinvar id is 330158.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-54930627-A-G is described in Lovd as [Benign].

BA1

GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.698 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	Protein	UniProt
NLRP7	NM_001127255.2 link	c.2682T>C	p.Tyr894Tyr	synonymous_variant	Exon 9 of 11	NP_001120727.1	Q8WX94-3
NLRP7	NM_001405531.1 link	c.2682T>C	p.Tyr894Tyr	synonymous_variant	Exon 11 of 13	NP_001392460.1
NLRP7	NM_139176.4 link	c.2598T>C	p.Tyr866Tyr	synonymous_variant	Exon 9 of 11	NP_631915.2	Q8WX94-2

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
NLRP7	ENST00000592784.6 link	c.2682T>C	p.Tyr894Tyr	synonymous_variant	Exon 9 of 11	1		ENSP00000468706.1		Q8WX94-3

Frequencies

GnomAD3 genomes

AF:

0.554

AC:

84139

AN:

151824

Hom.:

23559

Cov.:

show subpopulations

Gnomad AFR

AF:

0.518

Gnomad AMI

AF:

0.288

Gnomad AMR

AF:

0.577

Gnomad ASJ

AF:

0.627

Gnomad EAS

AF:

0.716

Gnomad SAS

AF:

0.636

Gnomad FIN

AF:

0.552

Gnomad MID

AF:

0.573

Gnomad NFE

AF:

0.553

Gnomad OTH

AF:

0.552

GnomAD3 exomes

AF:

0.588

AC:

147809

AN:

251440

Hom.:

44097

AF XY:

0.589

AC XY:

80048

AN XY:

135896

show subpopulations

Gnomad AFR exome

AF:

0.519

Gnomad AMR exome

AF:

0.645

Gnomad ASJ exome

AF:

0.628

Gnomad EAS exome

AF:

0.716

Gnomad SAS exome

AF:

0.630

Gnomad FIN exome

AF:

0.553

Gnomad NFE exome

AF:

0.553

Gnomad OTH exome

AF:

0.566

GnomAD4 exome

AF:

0.561

AC:

818657

AN:

1458364

Hom.:

231546

Cov.:

AF XY:

0.565

AC XY:

409847

AN XY:

725660

show subpopulations

Gnomad4 AFR exome

AF:

0.511

Gnomad4 AMR exome

AF:

0.639

Gnomad4 ASJ exome

AF:

0.627

Gnomad4 EAS exome

AF:

0.719

Gnomad4 SAS exome

AF:

0.637

Gnomad4 FIN exome

AF:

0.550

Gnomad4 NFE exome

AF:

0.546

Gnomad4 OTH exome

AF:

0.573

GnomAD4 genome

AF:

0.554

AC:

84203

AN:

151942

Hom.:

23580

Cov.:

AF XY:

0.557

AC XY:

41388

AN XY:

74254

show subpopulations

Gnomad4 AFR

AF:

0.518

Gnomad4 AMR

AF:

0.578

Gnomad4 ASJ

AF:

0.627

Gnomad4 EAS

AF:

0.717

Gnomad4 SAS

AF:

0.635

Gnomad4 FIN

AF:

0.552

Gnomad4 NFE

AF:

0.553

Gnomad4 OTH

AF:

0.550

Alfa

AF:

0.556

Hom.:

24813

Bravo

AF:

0.553

Asia WGS

AF:

0.619

AC:

2154

AN:

3478

EpiCase

AF:

0.555

EpiControl

AF:

0.552

ClinVar

Significance: Benign

Submissions summary: Benign:6

Revision: criteria provided, multiple submitters, no conflicts

LINK: link

Submissions by phenotype

Hydatidiform mole, recurrent, 1

Benign:3

Benign, no assertion criteria provided	clinical testing	Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen	-	- -
Benign, criteria provided, single submitter	clinical testing	Genome Diagnostics Laboratory, University Medical Center Utrecht	Oct 10, 2014	- -
Benign, criteria provided, single submitter	clinical testing	Illumina Laboratory Services, Illumina	Jan 12, 2018	This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified

Benign:1

Benign, criteria provided, single submitter

clinical testing

Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine

Mar 28, 2016

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Hydatidiform mole

Benign:1

Benign, criteria provided, single submitter

research

National Health Laboratory Service, Universitas Academic Hospital and University of the Free State

Feb 22, 2021

- -

not provided

Benign:1

Benign, criteria provided, single submitter

not provided

Breakthrough Genomics, Breakthrough Genomics

- -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

BayesDel_noAF

Benign

-1.0

CADD

Benign

0.23

DANN

Benign

0.27

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.0

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

LitVar

Other links and lift over